VitamaS.A.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-05-10
Share capital
30 476 100,00 PLN
Registered address
Powsińska 106, 02-903 Warszawa, Poland
Website
vitama.plWebsite active

Financials

The financial statement for 2023 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2022.

Results vs industry

Revenue
This companyUSD 4.29mMedianUSD 816.16kAverageUSD 29.28m
Net profit
This companyUSD 826.50kMedianUSD 8.96kAverageUSD 2.64m
Operating costs
This companyUSD 3.35mMedianUSD 701.47kAverageUSD 19.26m
Assets
This companyUSD 21.39mMedianUSD 800.13kAverageUSD 29.34m

Bank accounts

Registered as a VAT taxpayer on 2012-09-01. Active

  • mBank
    29 1140 1010 0000 5393 1800 1010

Debt

6 closed proceedings recorded in KRZ history. Closed proceedings in history

Registration dateProceeding typeStatus
May 31, 2025
Discontinued enforcement proceedings
Closed
Dec 23, 2024
Discontinued enforcement proceedings
Closed
Dec 12, 2024
Discontinued enforcement proceedings
Closed
Sep 5, 2023
Discontinued enforcement proceedings
Closed
Jul 4, 2023
Discontinued enforcement proceedings
Closed

MSiG notices

Publication dateEvent
May 19, 2022Call to creditors

Public aid

Grant datePurposeGross amountGranting body
Nov 16, 2020
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,396Prezes Zakładu Ubezpieczeń Społecznych
Jan 23, 2019
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$6,195Prezes Zakładu Ubezpieczeń Społecznych
Nov 21, 2017
Regional investment aid
$1,763,731Minister Funduszy i Polityki Regionalnej

Tenders

No recorded participation in tenders.

Authorized Representatives

Marek Kluczny — President of the Management Board

Manner of representation

Each member of the management board acting independently

Supervisory board

Andrzej Kosman — Supervisory Board Member
Ewa Lubicz Nowicka — Supervisory Board Member
Marcin Kaznowski — Supervisory Board Member

Beneficial owners

PersonRights
Cezary Robert Kilczewski (61)
Posiada 80,95 % akcji w spółce medicofarma s.a.będącej właścicielem 93% zgłaszanej spółki akcyjnej

Subsidiaries

NameShare valueStake
Elopharmsp. z o.o.
13,506.21 USD50%

Competitors

Change history

DateEvent
2024-08-30Address change (Bonifraterska 17, 00-203, Warszawa → Powsińska 106, 02-903, Warszawa)
2022-11-30Share capital change (30,467,100.00 PLN → 30,476,100.00 PLN)
2022-09-28Share capital change (32,770,000.00 PLN → 30,467,100.00 PLN)
2017-02-07Share capital change (15,100,000.00 PLN → 32,770,000.00 PLN)
2016-11-29Share capital change (100,000.00 PLN → 15,100,000.00 PLN)

FAQ

Last updated: 2026-03-24